Market Analysis and Insights: Global Targeted Drug Delivery System Market
The global Targeted Drug Delivery System market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Targeted Drug Delivery System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Targeted Drug Delivery System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Targeted Drug Delivery System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Targeted Drug Delivery System include 3M Company, Abbott Laboratories, Ablynx NV, Aciont Inc, Acrux, Agilis BiOthersapeutics LLC, Aileron Therapeutics Inc, Nano Precision Medical Inc and Novartis Pharmaceuticals Corp, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Targeted Drug Delivery System market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Targeted Drug Delivery System, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Targeted Drug Delivery System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Targeted Drug Delivery System revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Targeted Drug Delivery System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Targeted Drug Delivery System revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including 3M Company, Abbott Laboratories, Ablynx NV, Aciont Inc, Acrux, Agilis BiOthersapeutics LLC, Aileron Therapeutics Inc, Nano Precision Medical Inc and Novartis Pharmaceuticals Corp, etc.
By Company
3M Company
Abbott Laboratories
Ablynx NV
Aciont Inc
Acrux
Agilis BiOthersapeutics LLC
Aileron Therapeutics Inc
Nano Precision Medical Inc
Novartis Pharmaceuticals Corp
Oxford Biomedica
PharmaIN Corp
PolyMicrospheres
Presage Biosciences Inc
Pulmatrix Inc
Quark Pharmaceuticals Inc
RegeneRx Biopharmaceuticals Inc
Replicor Inc
Rexahn Pharmaceuticals Inc
Roche Holding AG
Savara Inc
Serina Therapeutics Inc.
Silenseed Ltd.
SoluBest Ltd
Suda Ltd
Taiwan Liposome Co. Ltd.
Pipeline
Vect-Horus S.A.S.
Vectura Group plc
WAVE Life Sciences Pvt. Ltd.
Xigen SA
Segment by Type
Nano Tubes
Nano Wires
Nano Shells
Quantum Dots
Nano Pros
Segment by Application
First Order Targeting (Organ Compartmentalization)
Second Order Targeting (Cellular Targeting)
Third Order Targeting (Intracellular Targeting)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Targeted Drug Delivery System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Drug Delivery System companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Targeted Drug Delivery System revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Drug Delivery System Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Nano Tubes
1.2.3 Nano Wires
1.2.4 Nano Shells
1.2.5 Quantum Dots
1.2.6 Nano Pros
1.3 Market by Application
1.3.1 Global Targeted Drug Delivery System Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 First Order Targeting (Organ Compartmentalization)
1.3.3 Second Order Targeting (Cellular Targeting)
1.3.4 Third Order Targeting (Intracellular Targeting)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Drug Delivery System Market Perspective (2018-2029)
2.2 Global Targeted Drug Delivery System Growth Trends by Region
2.2.1 Targeted Drug Delivery System Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Targeted Drug Delivery System Historic Market Size by Region (2018-2023)
2.2.3 Targeted Drug Delivery System Forecasted Market Size by Region (2024-2029)
2.3 Targeted Drug Delivery System Market Dynamics
2.3.1 Targeted Drug Delivery System Industry Trends
2.3.2 Targeted Drug Delivery System Market Drivers
2.3.3 Targeted Drug Delivery System Market Challenges
2.3.4 Targeted Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Targeted Drug Delivery System by Players
3.1.1 Global Targeted Drug Delivery System Revenue by Players (2018-2023)
3.1.2 Global Targeted Drug Delivery System Revenue Market Share by Players (2018-2023)
3.2 Global Targeted Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Targeted Drug Delivery System, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Targeted Drug Delivery System Market Concentration Ratio
3.4.1 Global Targeted Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Drug Delivery System Revenue in 2022
3.5 Global Key Players of Targeted Drug Delivery System Head office and Area Served
3.6 Global Key Players of Targeted Drug Delivery System, Product and Application
3.7 Global Key Players of Targeted Drug Delivery System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Drug Delivery System Breakdown Data by Type
4.1 Global Targeted Drug Delivery System Historic Market Size by Type (2018-2023)
4.2 Global Targeted Drug Delivery System Forecasted Market Size by Type (2024-2029)
5 Targeted Drug Delivery System Breakdown Data by Application
5.1 Global Targeted Drug Delivery System Historic Market Size by Application (2018-2023)
5.2 Global Targeted Drug Delivery System Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Targeted Drug Delivery System Market Size (2018-2029)
6.2 North America Targeted Drug Delivery System Market Size by Type
6.2.1 North America Targeted Drug Delivery System Market Size by Type (2018-2023)
6.2.2 North America Targeted Drug Delivery System Market Size by Type (2024-2029)
6.2.3 North America Targeted Drug Delivery System Market Share by Type (2018-2029)
6.3 North America Targeted Drug Delivery System Market Size by Application
6.3.1 North America Targeted Drug Delivery System Market Size by Application (2018-2023)
6.3.2 North America Targeted Drug Delivery System Market Size by Application (2024-2029)
6.3.3 North America Targeted Drug Delivery System Market Share by Application (2018-2029)
6.4 North America Targeted Drug Delivery System Market Size by Country
6.4.1 North America Targeted Drug Delivery System Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Targeted Drug Delivery System Market Size by Country (2018-2023)
6.4.3 North America Targeted Drug Delivery System Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Targeted Drug Delivery System Market Size (2018-2029)
7.2 Europe Targeted Drug Delivery System Market Size by Type
7.2.1 Europe Targeted Drug Delivery System Market Size by Type (2018-2023)
7.2.2 Europe Targeted Drug Delivery System Market Size by Type (2024-2029)
7.2.3 Europe Targeted Drug Delivery System Market Share by Type (2018-2029)
7.3 Europe Targeted Drug Delivery System Market Size by Application
7.3.1 Europe Targeted Drug Delivery System Market Size by Application (2018-2023)
7.3.2 Europe Targeted Drug Delivery System Market Size by Application (2024-2029)
7.3.3 Europe Targeted Drug Delivery System Market Share by Application (2018-2029)
7.4 Europe Targeted Drug Delivery System Market Size by Country
7.4.1 Europe Targeted Drug Delivery System Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Targeted Drug Delivery System Market Size by Country (2018-2023)
7.4.3 Europe Targeted Drug Delivery System Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Targeted Drug Delivery System Market Size (2018-2029)
8.2 China Targeted Drug Delivery System Market Size by Type
8.2.1 China Targeted Drug Delivery System Market Size by Type (2018-2023)
8.2.2 China Targeted Drug Delivery System Market Size by Type (2024-2029)
8.2.3 China Targeted Drug Delivery System Market Share by Type (2018-2029)
8.3 China Targeted Drug Delivery System Market Size by Application
8.3.1 China Targeted Drug Delivery System Market Size by Application (2018-2023)
8.3.2 China Targeted Drug Delivery System Market Size by Application (2024-2029)
8.3.3 China Targeted Drug Delivery System Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Targeted Drug Delivery System Market Size (2018-2029)
9.2 Asia Targeted Drug Delivery System Market Size by Type
9.2.1 Asia Targeted Drug Delivery System Market Size by Type (2018-2023)
9.2.2 Asia Targeted Drug Delivery System Market Size by Type (2024-2029)
9.2.3 Asia Targeted Drug Delivery System Market Share by Type (2018-2029)
9.3 Asia Targeted Drug Delivery System Market Size by Application
9.3.1 Asia Targeted Drug Delivery System Market Size by Application (2018-2023)
9.3.2 Asia Targeted Drug Delivery System Market Size by Application (2024-2029)
9.3.3 Asia Targeted Drug Delivery System Market Share by Application (2018-2029)
9.4 Asia Targeted Drug Delivery System Market Size by Region
9.4.1 Asia Targeted Drug Delivery System Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Targeted Drug Delivery System Market Size by Region (2018-2023)
9.4.3 Asia Targeted Drug Delivery System Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Targeted Drug Delivery System Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Targeted Drug Delivery System Market Size by Type
10.2.1 Middle East, Africa, and Latin America Targeted Drug Delivery System Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Targeted Drug Delivery System Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Targeted Drug Delivery System Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Targeted Drug Delivery System Market Size by Application
10.3.1 Middle East, Africa, and Latin America Targeted Drug Delivery System Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Targeted Drug Delivery System Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Targeted Drug Delivery System Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Targeted Drug Delivery System Market Size by Country
10.4.1 Middle East, Africa, and Latin America Targeted Drug Delivery System Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Targeted Drug Delivery System Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Targeted Drug Delivery System Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 3M Company
11.1.1 3M Company Company Details
11.1.2 3M Company Business Overview
11.1.3 3M Company Targeted Drug Delivery System Introduction
11.1.4 3M Company Revenue in Targeted Drug Delivery System Business (2018-2023)
11.1.5 3M Company Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Targeted Drug Delivery System Introduction
11.2.4 Abbott Laboratories Revenue in Targeted Drug Delivery System Business (2018-2023)
11.2.5 Abbott Laboratories Recent Developments
11.3 Ablynx NV
11.3.1 Ablynx NV Company Details
11.3.2 Ablynx NV Business Overview
11.3.3 Ablynx NV Targeted Drug Delivery System Introduction
11.3.4 Ablynx NV Revenue in Targeted Drug Delivery System Business (2018-2023)
11.3.5 Ablynx NV Recent Developments
11.4 Aciont Inc
11.4.1 Aciont Inc Company Details
11.4.2 Aciont Inc Business Overview
11.4.3 Aciont Inc Targeted Drug Delivery System Introduction
11.4.4 Aciont Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.4.5 Aciont Inc Recent Developments
11.5 Acrux
11.5.1 Acrux Company Details
11.5.2 Acrux Business Overview
11.5.3 Acrux Targeted Drug Delivery System Introduction
11.5.4 Acrux Revenue in Targeted Drug Delivery System Business (2018-2023)
11.5.5 Acrux Recent Developments
11.6 Agilis BiOthersapeutics LLC
11.6.1 Agilis BiOthersapeutics LLC Company Details
11.6.2 Agilis BiOthersapeutics LLC Business Overview
11.6.3 Agilis BiOthersapeutics LLC Targeted Drug Delivery System Introduction
11.6.4 Agilis BiOthersapeutics LLC Revenue in Targeted Drug Delivery System Business (2018-2023)
11.6.5 Agilis BiOthersapeutics LLC Recent Developments
11.7 Aileron Therapeutics Inc
11.7.1 Aileron Therapeutics Inc Company Details
11.7.2 Aileron Therapeutics Inc Business Overview
11.7.3 Aileron Therapeutics Inc Targeted Drug Delivery System Introduction
11.7.4 Aileron Therapeutics Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.7.5 Aileron Therapeutics Inc Recent Developments
11.8 Nano Precision Medical Inc
11.8.1 Nano Precision Medical Inc Company Details
11.8.2 Nano Precision Medical Inc Business Overview
11.8.3 Nano Precision Medical Inc Targeted Drug Delivery System Introduction
11.8.4 Nano Precision Medical Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.8.5 Nano Precision Medical Inc Recent Developments
11.9 Novartis Pharmaceuticals Corp
11.9.1 Novartis Pharmaceuticals Corp Company Details
11.9.2 Novartis Pharmaceuticals Corp Business Overview
11.9.3 Novartis Pharmaceuticals Corp Targeted Drug Delivery System Introduction
11.9.4 Novartis Pharmaceuticals Corp Revenue in Targeted Drug Delivery System Business (2018-2023)
11.9.5 Novartis Pharmaceuticals Corp Recent Developments
11.10 Oxford Biomedica
11.10.1 Oxford Biomedica Company Details
11.10.2 Oxford Biomedica Business Overview
11.10.3 Oxford Biomedica Targeted Drug Delivery System Introduction
11.10.4 Oxford Biomedica Revenue in Targeted Drug Delivery System Business (2018-2023)
11.10.5 Oxford Biomedica Recent Developments
11.11 PharmaIN Corp
11.11.1 PharmaIN Corp Company Details
11.11.2 PharmaIN Corp Business Overview
11.11.3 PharmaIN Corp Targeted Drug Delivery System Introduction
11.11.4 PharmaIN Corp Revenue in Targeted Drug Delivery System Business (2018-2023)
11.11.5 PharmaIN Corp Recent Developments
11.12 PolyMicrospheres
11.12.1 PolyMicrospheres Company Details
11.12.2 PolyMicrospheres Business Overview
11.12.3 PolyMicrospheres Targeted Drug Delivery System Introduction
11.12.4 PolyMicrospheres Revenue in Targeted Drug Delivery System Business (2018-2023)
11.12.5 PolyMicrospheres Recent Developments
11.13 Presage Biosciences Inc
11.13.1 Presage Biosciences Inc Company Details
11.13.2 Presage Biosciences Inc Business Overview
11.13.3 Presage Biosciences Inc Targeted Drug Delivery System Introduction
11.13.4 Presage Biosciences Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.13.5 Presage Biosciences Inc Recent Developments
11.14 Pulmatrix Inc
11.14.1 Pulmatrix Inc Company Details
11.14.2 Pulmatrix Inc Business Overview
11.14.3 Pulmatrix Inc Targeted Drug Delivery System Introduction
11.14.4 Pulmatrix Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.14.5 Pulmatrix Inc Recent Developments
11.15 Quark Pharmaceuticals Inc
11.15.1 Quark Pharmaceuticals Inc Company Details
11.15.2 Quark Pharmaceuticals Inc Business Overview
11.15.3 Quark Pharmaceuticals Inc Targeted Drug Delivery System Introduction
11.15.4 Quark Pharmaceuticals Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.15.5 Quark Pharmaceuticals Inc Recent Developments
11.16 RegeneRx Biopharmaceuticals Inc
11.16.1 RegeneRx Biopharmaceuticals Inc Company Details
11.16.2 RegeneRx Biopharmaceuticals Inc Business Overview
11.16.3 RegeneRx Biopharmaceuticals Inc Targeted Drug Delivery System Introduction
11.16.4 RegeneRx Biopharmaceuticals Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.16.5 RegeneRx Biopharmaceuticals Inc Recent Developments
11.17 Replicor Inc
11.17.1 Replicor Inc Company Details
11.17.2 Replicor Inc Business Overview
11.17.3 Replicor Inc Targeted Drug Delivery System Introduction
11.17.4 Replicor Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.17.5 Replicor Inc Recent Developments
11.18 Rexahn Pharmaceuticals Inc
11.18.1 Rexahn Pharmaceuticals Inc Company Details
11.18.2 Rexahn Pharmaceuticals Inc Business Overview
11.18.3 Rexahn Pharmaceuticals Inc Targeted Drug Delivery System Introduction
11.18.4 Rexahn Pharmaceuticals Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.18.5 Rexahn Pharmaceuticals Inc Recent Developments
11.19 Roche Holding AG
11.19.1 Roche Holding AG Company Details
11.19.2 Roche Holding AG Business Overview
11.19.3 Roche Holding AG Targeted Drug Delivery System Introduction
11.19.4 Roche Holding AG Revenue in Targeted Drug Delivery System Business (2018-2023)
11.19.5 Roche Holding AG Recent Developments
11.20 Savara Inc
11.20.1 Savara Inc Company Details
11.20.2 Savara Inc Business Overview
11.20.3 Savara Inc Targeted Drug Delivery System Introduction
11.20.4 Savara Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.20.5 Savara Inc Recent Developments
11.21 Serina Therapeutics Inc.
11.21.1 Serina Therapeutics Inc. Company Details
11.21.2 Serina Therapeutics Inc. Business Overview
11.21.3 Serina Therapeutics Inc. Targeted Drug Delivery System Introduction
11.21.4 Serina Therapeutics Inc. Revenue in Targeted Drug Delivery System Business (2018-2023)
11.21.5 Serina Therapeutics Inc. Recent Developments
11.22 Silenseed Ltd.
11.22.1 Silenseed Ltd. Company Details
11.22.2 Silenseed Ltd. Business Overview
11.22.3 Silenseed Ltd. Targeted Drug Delivery System Introduction
11.22.4 Silenseed Ltd. Revenue in Targeted Drug Delivery System Business (2018-2023)
11.22.5 Silenseed Ltd. Recent Developments
11.23 SoluBest Ltd
11.23.1 SoluBest Ltd Company Details
11.23.2 SoluBest Ltd Business Overview
11.23.3 SoluBest Ltd Targeted Drug Delivery System Introduction
11.23.4 SoluBest Ltd Revenue in Targeted Drug Delivery System Business (2018-2023)
11.23.5 SoluBest Ltd Recent Developments
11.24 Suda Ltd
11.24.1 Suda Ltd Company Details
11.24.2 Suda Ltd Business Overview
11.24.3 Suda Ltd Targeted Drug Delivery System Introduction
11.24.4 Suda Ltd Revenue in Targeted Drug Delivery System Business (2018-2023)
11.24.5 Suda Ltd Recent Developments
11.25 Taiwan Liposome Co. Ltd.
11.25.1 Taiwan Liposome Co. Ltd. Company Details
11.25.2 Taiwan Liposome Co. Ltd. Business Overview
11.25.3 Taiwan Liposome Co. Ltd. Targeted Drug Delivery System Introduction
11.25.4 Taiwan Liposome Co. Ltd. Revenue in Targeted Drug Delivery System Business (2018-2023)
11.25.5 Taiwan Liposome Co. Ltd. Recent Developments
11.26 Pipeline
11.26.1 Pipeline Company Details
11.26.2 Pipeline Business Overview
11.26.3 Pipeline Targeted Drug Delivery System Introduction
11.26.4 Pipeline Revenue in Targeted Drug Delivery System Business (2018-2023)
11.26.5 Pipeline Recent Developments
11.27 Vect-Horus S.A.S.
11.27.1 Vect-Horus S.A.S. Company Details
11.27.2 Vect-Horus S.A.S. Business Overview
11.27.3 Vect-Horus S.A.S. Targeted Drug Delivery System Introduction
11.27.4 Vect-Horus S.A.S. Revenue in Targeted Drug Delivery System Business (2018-2023)
11.27.5 Vect-Horus S.A.S. Recent Developments
11.28 Vectura Group plc
11.28.1 Vectura Group plc Company Details
11.28.2 Vectura Group plc Business Overview
11.28.3 Vectura Group plc Targeted Drug Delivery System Introduction
11.28.4 Vectura Group plc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.28.5 Vectura Group plc Recent Developments
11.29 WAVE Life Sciences Pvt. Ltd.
11.29.1 WAVE Life Sciences Pvt. Ltd. Company Details
11.29.2 WAVE Life Sciences Pvt. Ltd. Business Overview
11.29.3 WAVE Life Sciences Pvt. Ltd. Targeted Drug Delivery System Introduction
11.29.4 WAVE Life Sciences Pvt. Ltd. Revenue in Targeted Drug Delivery System Business (2018-2023)
11.29.5 WAVE Life Sciences Pvt. Ltd. Recent Developments
11.30 Xigen SA
11.30.1 Xigen SA Company Details
11.30.2 Xigen SA Business Overview
11.30.3 Xigen SA Targeted Drug Delivery System Introduction
11.30.4 Xigen SA Revenue in Targeted Drug Delivery System Business (2018-2023)
11.30.5 Xigen SA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
3M Company
Abbott Laboratories
Ablynx NV
Aciont Inc
Acrux
Agilis BiOthersapeutics LLC
Aileron Therapeutics Inc
Nano Precision Medical Inc
Novartis Pharmaceuticals Corp
Oxford Biomedica
PharmaIN Corp
PolyMicrospheres
Presage Biosciences Inc
Pulmatrix Inc
Quark Pharmaceuticals Inc
RegeneRx Biopharmaceuticals Inc
Replicor Inc
Rexahn Pharmaceuticals Inc
Roche Holding AG
Savara Inc
Serina Therapeutics Inc.
Silenseed Ltd.
SoluBest Ltd
Suda Ltd
Taiwan Liposome Co. Ltd.
Pipeline
Vect-Horus S.A.S.
Vectura Group plc
WAVE Life Sciences Pvt. Ltd.
Xigen SA
听
听
*If Applicable.
